Concepedia

David M. Richards

DM

20

Publications

1.5K

Citations

18

H-Index

1962

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Salford Royal Hospital

Central South University

Second Xiangya Hospital of Central South University

Champalimaud Foundation

David M. Richards is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, gastroenterology, and oncology.

ORCID

Top concepts

Publications per year

1962–2024

20

Publications

20

Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis

Yinghong Wang, Hamzah Abu‐Sbeih, Emily Mao et al. · Inflammatory Bowel Diseases · 2018 · 238 citations

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study

Hamzah Abu‐Sbeih, Faisal S. Ali, Dana Alsaadi et al. · Journal for ImmunoTherapy of Cancer · 2018 · 206 citations · Full text

Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study

Laura M. Fernández, Guilherme Pagin São Julião, Nuno Figueiredo et al. · The Lancet Oncology · 2020 · 202 citations · Full text

, , +11

Assessing the quality of life of patients with intestinal failure on home parenteral nutrition.

David M. Richards, M H Irving · Gut · 1997 · 124 citations · Full text

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

Fangwen Zou, David M. Faleck, Anusha Shirwaikar Thomas et al. · Journal for ImmunoTherapy of Cancer · 2021 · 111 citations · Full text

Rows per page

1–5 of 20